New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...
September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 30, 2016 — Medtronic plc announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee ...

August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St. Jude ...
August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...
August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous ...

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont ...
July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) ...
June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom ...